October 27, 2022 – Central African Republic News Gazette

October 27, 2022

Huawei’s Yang Chaobin Launches All-Band 5G Solution Series

BANGKOK, Oct. 27, 2022 /PRNewswire/ — At the Global Mobile Broadband Forum 2022 (MBBF2022), Yang Chaobin, President of Huawei ICT Products & Solutions and Huawei Wireless Solution, releases One 5G concept and set of solutions designed to facilitate the evolution of all bands to 5G. “5G is in the fast lane,” Mr. Yang said. “The future calls for the evolution of all bands to 5G. Huawei’s All-Band 5G Solution series will help customers build 5G networks with optimal performance, ultimate experiences, and minimal energy consumption.”

5G has been commercialized for three years. It has developed rapidly in terms of network coverage, devices, and user scale. 5G delivers a more HD and immersive digital experience to consumers, and has accelerated digital transformation across industries. It has improved the way people work and the production efficiency of industries. In terms of 5G network construction, operators focused on TDD and mmWave development during the initial phase, but recently TDD+FDD convergence has been the choice for most operators.

Moving forward, all connections and services will evolve to 5G, and so will all bands. Huawei has developed the One 5G concept and solutions to maximize the capabilities of all bands, and facilitate in-depth coordination between bands, which lays the groundwork for the construction of efficient and cost-effective 5G networks.

MetaAAU with ELAA Improves TDD Uplink and Downlink Coverage While Reducing Energy Consumption

Combination of TDD high bandwidth and Massive MIMO has enabled cross-generation 5G experience. It is important to provide better coverage and higher capacity with lower energy consumption, which has inspired a series of new TDD Massive MIMO solutions.

Huawei’s MetaAAU boosts performance and energy efficiency to new levels, by making use of extremely large antenna array (ELAA) technology, as well as innovative software and hardware coordination. MetaAAU has been deployed at scale around the world. It has been proven to boost uplink and downlink coverage and user experience, while consuming less energy.

Products with wider bandwidth will be a must-have for operators to fulfill new band allocation needs and simplify the ultra-wide bandwidth deployment. Huawei’s new 800 MHz MetaAAU supports current deployment on C-Band and enables simplified deployment on future new spectrum.

For scenarios with limited antenna installation space, Huawei provides Meta BladeAAU, which combines Meta and Blade technologies in a unique way, to allow for easy deployment of MetaAAU and all sub-3GHz bands on a single pole, making it ideal for single-antenna scenarios.

Ultra-wideband and Multi-antenna Technologies Simplify Deployment with Fragmented FDD Spectrum and Improve Spectral Efficiency

Legacy FDD bands will continue to evolve to 5G. This process may meet challenges of the fragmented spectrum of narrow-band and co-existence of multi-RATs.

Huawei has been upgrading its ultra-wideband and multi-antenna solution series to help operators simplify deployment, improve spectral efficiency, and provide high-level user experience for all RATs.

Huawei’s ultra-wideband 4T4R RRU supports simplified multi-band network deployment on 700–900 MHz or 1.8–2.6/1.4 GHz, and millisecond-level power sharing across all carriers, bands, and RATs, which reduces power consumption while ensuring GU coverage.

Another Huawei product, ultra-wide band 8T8R RRU can increase 4G and 5G network capacity by 1.5 and 3 times, respectively. Together with the Hertz platform antenna which having built-in signal direct injection feeding (SDIF) technology, 8T8R RRU is able to reduce energy consumption.

For scenarios requiring a large capacity, Huawei provides FDD Massive MIMO AAU, which can increase 4G and 5G network capacity by 3 and 5 times, respectively, enhancing 4G and 5G performance. This product has been commercially deployed at scale on over 70 networks around the world.

For single-pole scenarios, Huawei provides the FDD BladeAAU solution, which is the industry’s first to combine FDD Massive MIMO AAUs and sub-3 GHz passive antennas. It allows for simple deployment on one pole.

LampSite and RuralLink Solutions Enable Ubiquitous 5G

Considering that 70% of wireless network traffic comes from the indoor scenarios, Huawei has developed the LampSite 5.0 solution that features TDD+FDD multi-band and multi-RAT combination. Thanks to a highly-integrated design, LampSite 5.0 reduces hardware weight and volume while reducing power consumption. In addition, mmWave is introduced for the LampSite solution to deliver indoor 10 Gbps capacity based on ultra-wide bandwidth and distributed architecture.

Huawei has also launched the RuralLink solution that is designed for remote areas. With this solution, a single RRU and antenna are all that’s needed to provide rural coverage for three sectors, and microwave fronthaul can save BBU deployment on the site. The inter-site distance between RuralLink site and host site is up to 20 km. With simplified design and ultra-low power consumption, only 6 solar panels are enough to power a single site and remote O&M is supported.

I nnovative mmWave Solution Enables mmWave Commercial Deployment in Outdoor Hotspots and Indoor Scenarios

mmWave spectrum resources are abundant, and more than 140 operators have obtained access to the high-bandwidth spectrum. Outdoor hotspots and indoor environments are typical application scenarios of mmWave.

In outdoor hotspot scenarios, Huawei’s mmWave solution makes use of iBeam and intelligent high- and low-band coordination algorithm to achieve precise beam alignment and fast tracking. Performance under continuous networking reveals that a continuous high user-perceived rate can be delivered in moving vehicles and indoor environments along streets.

In indoor scenarios, Huawei’s LampSite 5.0, supporting 800 MHz mmWave, C-band, and the 1.8 GHz band, works with the distributed architecture, providing an ultra-large capacity of more than 10 Gbps. These new capabilities will also make indoor connections seamless while unlocking the full potential of mmWave.

IntelligentRAN Empowers Intelligent 5G Networks

As all bands evolve to 5G, intelligent networks are needed to support the requirements of diversified services, enhance multi-RAT O&M efficiency, and balance user experience and energy consumption. With layered intelligence architecture, Huawei’s IntelligentRAN helps operators reduce network O&M costs, open network capabilities, and create more business opportunities.

The combination of One 5G all-band solutions and IntelligentRAN unlocks the full potential of all bands including TDD, FDD, and mmWave, and facilitates all-band coordination for better network performance and lower power consumption, following the principle: Bands Work As One and Networks Work As One.

“This is the best of times,” concluded Mr. Yang. “5G is entering a new era. Let’s continue 5G innovation with the goal of fulfilling the vision of reshaping the world with 5G, and stride towards the intelligent world.”

The Global Mobile Broadband Forum 2022 is hosted by Huawei, together with its industry partners GSMA and GTI. This annual forum gathers mobile network carriers, vertical industry leaders, and ecosystem partners from around the world to discuss how to make 5G a commercial success, as well as other high-priority industry topics like green development, intelligence, and 5G evolution. For more information, please visit:

https://www.huawei.com/en/events/mbbf2022.

Photo – https://mma.prnewswire.com/media/1931498/Yang_Chaobin_speaking_MBBF2022.jpg

October 27, 2022

Huawei’s Wang Jinping: Expand the Experience Dividend Pattern and Lead the Era of Experience-based Network Operations

BANGKOK, Oct. 27, 2022 /PRNewswire/ — The 14th Huawei User Group Meeting was held in Bangkok, Thailand. During the meeting, Wang Jinping, Marketing Director of Huawei NCE Optical Network Domain, delivered a speech saying that Huawei’s Premium Broadband solution can effectively help carriers to implement user experience operations, seize business growth opportunities and provide users with quality experience.

Nowadays users have high requirements for premium HBB experience, and users want a better network experience even if it comes at a higher cost.

Wang Jinping also mentioned that carriers should develop HBB services from the following three aspects:

To meet the requirements of various services and the huge potential user market, apply intelligent technologies to improve the accuracy of identifying potential users and increase the marketing success rate, thus quickly gaining market share.
Ensure the device-network-service matching, construct networks based on user experience requirements, and maximize the return on investment (ROI).
Build capabilities that help perceive user experience to improve HBB user experience and user satisfaction, thereby improving brand reputation and achieving service growth.

To help carriers realize these goals, Huawei launched the Premium Broadband solution outside China for the first time. In this solution, intelligent AEC boards are installed on OLTs to collect application KPIs such as delay and jitter in real time so that user experience can be accurately and effectively perceived. In addition, the collaboration between iMaster NCE (a management, control, and analysis system which provides the big data intelligent analysis capability) and Agile Digital Operations (ADO) helps carriers gain dividends from HBB user experience operations.

Insights into Experience Requirements, Facilitating Marketing Growth

In this solution, the potential user identification model is optimized from being single-dimensional to being multidimensional, helping carriers perceive user experience requirements. Accordingly, the marketing department can formulate marketing strategies to meet user requirements.

Device-Network-Service Matching, Facilitating Orderly Network Upgrades

In this solution, carriers can further ensure the correctness of device-network-service mapping, upgrade networks in an orderly manner, and provide basic assurance for high-quality HBB connections and optimal experience.

Minutes-level Experience Perception, Improving Passive Responses to Proactive Services

This solution integrates the upgraded perception capability, which implements minutes-level perception of poor-QoE issues. It changes the passive perception mode to the brand-new proactive experience perception and assurance mode, helping carriers to improve the user retention rate and user satisfaction.

The Premium Broadband solution has been widely commercially deployed in China. In Henan, the marketing success rate increased from 3% to 10% and the network ROI was improved by 40%. In Zhejiang, the poor-QoE rate decreased from 4.3% to 2.7% and complaints per 10,000 users decreased from 165 to 95.

According to Wang Jinping, through solution enablement and joint verification of best practices, user experience operations will truly facilitate development, further broaden business boundaries, and expand the dividend pattern.

CONTACT: Peng Cai, felix.cai@huawei.com

October 27, 2022

Arthur D. Little Publishes New Report On Innovation In Life Sciences

LONDON, Oct. 27, 2022 (GLOBE NEWSWIRE) — Arthur D. Little (ADL) has launched a report on current and future transformation in healthcare, and the effect these far-reaching changes will have on the life sciences and insurance sectors. To asssess that from more than one perspective, ADL and Munich Re, a leading provider of reinsurance, primary insurance and insurance-related risk solutions, have pooled their expertise and recommendations.

The combination of aging populations, changing urban and work environments, technical innovations in data processing and analysis, and current advances in diagnosing and treating diseases will not only dramatically transform healthcare but also our way of living. Healthcare systems and wider society must therefore prepare for these innovations to ensure preparedness and greater resilience.

Disruptive developments such as digitization, far-reaching advances in medical technology, and the latest findings in life sciences interrelate and reinforce each other to an unprecedented extent. Consequently, the report sets out how everyone within the ecosystem needs to collaborate around a common goal – bringing innovations to patients faster and pushing the boundaries of insurability.

Describing the impacts of transformation and providing insights, imperatives and key takeaways for both the insurance and life sciences industries, the report focuses on opportunities in five key areas of healthcare:

–        Digital Health
–        Advanced therapeutics & new paradigms in treatments
–        Power of genes & omics
–        Mental health
–        Pandemic risk

Dr. Ulrica Sehlstedt, Managing Partner, and Global Practice Leader, Healthcare & Life Sciences at Arthur D. Little, comments: “Innovation is driving a revolution at every step of the patient journey. This impacts every player within the life sciences and healthcare industry, including insurance companies. The imperative is on the whole ecosystem to work together to provide positive solutions and mitigate current and future risks, which is why we are delighted that Munich Re has contributed to bring together knowledge, experience and perspectives within this in-depth report.”

Dr. Franziska Thomas, Partner and Head of Healthcare & Life Sciences of Arthur D. Little Germany, comments: “The last two years has seen an enormous acceleration in multiple areas of medicine – and indeed across wider society. The patient journey is transforming to become more personalized and decentralized. As this report explains, it is only through convergence between all areas within the ecosystem that solutions can be delivered to meet the rapidly changing needs of patients.”

To download the report visit: https://tinyurl.com/mszkfz28

Further information from:	Cate Bonthuys / Sue Glanville
	Catalyst Comms
	+44 7746 546773
	info@catalystcomms.co.uk

A pdf accompanying this announcement is available at:

http://ml-eu.globenewswire.com/Resource/Download/703e8c10-23ce-43a1-8ad4-98c37003af32

GlobeNewswire Distribution ID 1000753249

October 27, 2022

/DISREGARD RELEASE: HuaWei/

We are advised by Huawei that journalists and other readers should disregard the news release, Huawei’s Yang Chaobin Launches All-Band 5G Solution Series, issued 26-Oct-2022 over PR Newswire.

October 27, 2022October 28, 2022

Voicing Concern over Renewed Violence in Abyei, Speakers in Security Council Urge Increased Dialogue between Khartoum, Juba towards Peaceful Settlement (SC/15083)

Amid a resurgence of violence and intercommunal attacks, Sudan and South Sudan must continue their political engagement for implementing security and administrative arrangements in Abyei, and achieving an acceptable solution on the final status of the Area, speakers told the Security Council today, as it also looked towards a renewal of the United Nations Interim Security Force for Abyei (UNISFA) mandate and the mission’s support to the Joint Border Verification and Monitoring Mechanism before they expire on 15 November.

Martha Ama Akyaa Pobee, Assistant Secretary-General for Africa, Departments of Political and Peacebuilding Affairs and Peace Operations, recalled the agreement earlier in the week between Sudan and South Sudan officials to enhance cooperation in addressing those issues, as well as their willingness to resume the meeting of the Abyei Joint Oversight Committee, which had not met since 2017. Noting the African Union’s various efforts, she welcomed the African Union High-level Implementation Panel’s effort to engage the local communities. UNISFA stands ready to support the shared objectives for Abyei, she affirmed, detailing its work with communities and leaders in Khartoum and Juba in that regard.

Although the security situation in the Abyei area remains mostly calm, a new conflict is emerging between the Dinka Ngoc and Twic communities in southern Abyei, she said, pointing out that much of the intercommunal violence there has related to that conflict with loss of lives on both sides and the displacement of thousands of civilians. UNISFA has intensified patrols to deter further violence, offering protection to those displaced and providing medical services. Clashes recently resumed after a lull in violence during the rainy season, she noted, warning that the upcoming dry season with improved conditions for mobility could bring further violence.

She reported that the reconfiguration of UNISFA into a multinational peacekeeping force continues and is near completion with 2,567 military personnel out of the authorized 3,250 personnel in place. Turning to the mission’s support for the Joint Verification and Monitoring Mechanism, she called on Juba to ensure re-operationalization of the Mechanism’s sites as soon as possible. During the reporting period, there was also no progress on deployment of three formed police units and individual police officers due to continued non-issuance of visas, she said, calling for the Council’s support in that regard.

Hanna Serwaa Tetteh, Special Envoy of the Secretary-General for the Horn of Africa, briefing the Council on progress in implementing resolution 2046 (2012), said that while Sudan and South Sudan have improved relations, through regular bilateral meetings, each country’s priority are on domestic issues. In Sudan, the parties are yet to agree on the way forward to restore a democratic transition after the coup of 25 October 2021; in South Kordofan and Blue Nile states, the stalemate in talks between the Government of Sudan and the Sudan People’s Liberation Movement-North (SPLM-N) led by Abdelaziz al-Hilu has persisted; while some progress was registered in the peace process in South Sudan, with the graduation of forces on 30 August.

Detailing her Office’s efforts to find a way out of the stalemate on the settlement of the final status, she pointed out that: “Meaningful progress in the negotiations appears unlikely absent the prior agreement on the restoration of a civilian led transitional Government in Khartoum.” Her Office will continue to engage with the Governments of Sudan and South Sudan, the African Union and the Intergovernmental Authority on Development (IGAD) towards fully normalizing relations between both countries.

In the ensuing debate, speakers welcomed positive steps in relations between Khartoum and Juba. They voiced concern, however, about the recent acts of violence between the Dinka Ngok and Twic communities and called on parties to cease hostilities. Many Council members expressed support for a one-year extension of UNISFA’s mandate and called on stakeholders’ strengthened engagement and dialogue to facilitate the work of the mission and advance on outstanding issues.

Ghana’s representative, also speaking for Gabon and Kenya, urged the two countries to seek a peaceful settlement on the final status of Abyei as provided in the Comprehensive Peace Agreement between the Government of Sudan and the Sudan People’s Liberation Movement/Army (SPLM/A) in 2005. Voicing concern about the resurgence of armed violence and intercommunal attacks in Abyei, he emphasized the need for more broad-based intercommunal dialogues to address grievances and tensions among the communities. Stressing the need to maintain UNISFA’s presence, he urged Sudan and South Sudan to fully cooperate with the mission, including full respect of the status-of-forces agreement.

The representative of the United States pointed out that a one-year extension of UNISFA’s mandate will allow the mission to complete its troop reconfiguration and give it adequate time to receive visas, identify key stakeholders and develop essential relationships required to implement its mandate. Condemning recent acts of violence between the Dinka Ngok and Twic communities, he urged Sudan and South Sudan to facilitate the smooth functioning of all UNISFA bases and the Joint Border Verification and Monitoring Mechanism’s team sites.

Ireland’s representative stressed: “We cannot let this become a forgotten crisis. Echoing other delegations, he voiced concern about the humanitarian situation as well as ongoing sexual and gender-based violence in Abyei. He joined other delegations in welcoming progress made in the reconfiguration of UNISFA to a multinational force and called on both parties to address outstanding operational issues, such as the issuance of visas and access to Athony airstrip.

South Sudan’s representative said that despite the incomplete deployment of the multinational force and intercommunal clashes leading to greater insecurity, his Government is working tirelessly to address the root causes of the conflict to restore and foster intercommunal harmony between the two communities. He called for the reconfiguration of the MINUSFA force to enable a rapid response to any security situation, as well as an early warning system to prevent and diffuse clashes.

Sudan’s representative underscored the need for the implementation of the political and legal terms of reference, including the interim security agreements concluded in 2012 and the Cooperation Agreement between the Republic of the Sudan and the Republic of South Sudan, until the two parties reach the solution on its final status. Stressing the interim nature of the mission in Abyei, with specifically agreed on tasks, he called for efforts to to bolster the work of the Joint Border Verification and Monitoring Mechanism, and to undertake humanitarian work to consolidate peaceful coexistence.

Source: UN Security Council

October 27, 2022October 28, 2022

Tuberculosis Cases on Rise After COVID-19, Reversing Years of Progress

Tuberculosis case numbers increased from 2019 to 2021, reversing years of progress as the COVID-19 pandemic disrupted access to treatment and testing, the World Health Organization said Thursday.

“For the first time in nearly two decades, WHO is reporting an increase in the number of people falling ill with TB and the drug-resistant tuberculosis, alongside an increase in TB related deaths,” said Tereza Kasaeva, director of the U.N. health agency’s global TB program.

A WHO report released Thursday stated that more than 10 million people got tuberculosis in 2021, a 4.5% increase from 2020. Roughly 450,000 cases involved individuals infected with the drug-resistant TB strain, a 3% increase from 2020 to 2021. Most of these cases were reported in India, Indonesia, Myanmar and the Philippines.

The COVID-19 pandemic “continues to have a damaging impact on access to TB diagnosis and treatment,” WHO said. COVID-19 restrictions, such as lockdowns and physical distancing, resulted in fewer people being diagnosed and getting the necessary treatment. With fewer people being diagnosed and treated for TB, more patients unknowingly spread the disease to others. As a result, more than a decade of progress was lost, said Dr. Mel Spigelman, president of the nonprofit TB Alliance.

Tuberculosis is caused by bacteria that attack the lungs. The disease is mainly spread through the air and, after COVID-19, tuberculosis is the world’s deadliest infectious disease. It primarily affects adults, particularly those who are malnourished or immunocompromised, in developing countries. More than 95% of cases are in developing countries.

The downturn of the global economy during the pandemic worsened the problem, as families faced unbearable costs due to their treatment, especially in developing countries.

Dr. Hannah Spencer, with Doctors Without Borders in South Africa, suggested lowering the prices of tuberculosis treatment to no more than $500 to help low-income patients. WHO also suggested that more countries should cover the cost of TB diagnosis and treatment.

“If the pandemic has taught us anything, it’s that with solidarity, determination, innovation and the equitable use of tools, we can overcome severe health threats,” WHO Director-General Tedros Adhanom Ghebreyesus said in a news release Thursday. “Let’s apply those lessons to tuberculosis. It is time to put a stop to this long-time killer.”

Source: Voice of America

October 27, 2022October 28, 2022

Canadian Parliament Urges Government to Accept 10,000 Uyghur Refugees

Members of the Canadian Parliament have urged the government to expedite the resettlement to Canada of Uyghur refugees now living in third countries.

The Parliament voted Tuesday on a motion from Conservative MP Garnett Genuis to reaffirm its recognition of the Uyghur genocide in China and to call for special immigration measures to assist Uyghur refugees at risk of deportation to China from third countries.

“House of Commons thankfully endorsed that motion,” Genuis told VOA.

Almost 50,000 Uyghur refugees are living in Turkey, and smaller numbers of Uyghurs who fled China are in countries such as Egypt and the United Arab Emirates, from where Uyghurs were deported to China in recent years.

Another motion, debated Wednesday in Parliament, calls on Ottawa to expedite the entry of Uyghur refugees.

“[My motion] calls on Canada to welcome 10,000 Uyghurs and other Turkic minorities over two years starting in 2024,” Sameer Zuberi, chair of Parliament’s Foreign Affairs subcommittee on international human rights, told VOA. “It builds on the House of Commons’ formal recognition in February 2021 that a genocide has been taking place against the Uyghur people.”

Genocide designation

Canada became the second country to recognize China’s treatment of Uyghurs as genocide in February 2021. The U.S. was the first country to designate human rights violations against Uyghurs in China as genocide in January of the same year. Other legislative bodies in Britain, the Netherlands, Belgium, France, Lithuania, the Czech Republic and Ireland have made similar determinations since.

The government of Canada has sanctioned four individuals and one entity for their roles in human rights violations in Xinjiang.

A report by the Canadian Parliament’s Foreign Affairs subcommittee on international human rights published in October 2020 contained recommendations calling on Canada to uphold basic human rights of Uyghurs and other Turkic peoples of the Xinjiang Uyghur Autonomous Region.

“One of the recommendations of this report is for the department of Immigration, Refugees and Citizenship Canada to expedite the entry into Canada of Uyghurs and other Turkic minorities,” Zuberi said. “If passed by the House of Commons, my motion will give life to this recommendation.”

According to Mehmet Tohti, executive director of Ottawa-based Uyghur Rights Advocacy Project, most Uyghur refugees who live in third countries are in danger of being sent back to China.

“Uyghurs who fled to countries like Turkey are vulnerable for being repatriated to China,” Tohti told VOA. “Countries like Turkey where most Uyghur refugees live depend on China economically and that can influence those countries’ decision on how to deal with Uyghur refugees, like intimidating them to return to China.”

Detention, deportation

According to a report released in June 2021 by the Oxus Society for Central Asian Affairs and Uyghur Human Rights Project, there were 1,546 cases of detention and deportation of Uyghurs in at least 28 countries between 1997 and March 2021.

“[M]ost notably in much of the Middle East and North Africa with 647 cases, and in South Asia with 665 cases,” the report said. “The dataset contains 1,151 cases of Uyghurs being detained in their host country and 395 cases of Uyghurs being deported, extradited or rendered back to China.”

“Uyghurs’ futures in those countries are far from certain. They do not have safe refuge,” Zuberi said. “In the spirit of Canada’s proud humanitarian tradition, where Yazidis, Syrians, Afghans and recently Ukrainians have been welcomed, I am hoping that Canada can again step up and resettle vulnerable Uyghurs.”

According to Zuberi, after Wednesday’s hour of debate of his motion at Parliament, there will be a second hour of debate in December, followed by a vote in mid-December or early February.

If endorsed, the bill requires that within 120 days following the adoption of the motion, a report must be completed on how the refugee resettlement plan would be implemented.

Human rights

Canada’s Immigration Ministry spokesperson, Remi Lariviere, said Canada is “deeply concerned about the serious human rights violations in Xinjiang affecting Uyghurs and other Muslim ethnic minorities, as outlined in a recent U.N. report.

“The Government of Canada remains committed to providing protection to vulnerable individuals in need of resettlement,” Lariviere told VOA in an email. “Our resettlement programs are available to those most in need of protection around the world, including Uyghurs and other Muslim ethnic minorities who have fled persecution in China.”

In August, the U.N. Human Rights Office asserted in a report on human rights in Xinjiang that China “may have committed crimes against humanity” against Uyghurs and other predominantly Muslim ethnic groups, including arbitrary detention, credible allegations of torture, forced labor, forced sterilization, sexual violence and adverse conditions of detention.

China claimed the U.N. report was based on “disinformation and draws erroneous conclusions” about human rights in Xinjiang.

According to Lariviere, Canada relies on referrals from the U.N. refugee agency (UNHCR), other designated referral organizations and private sponsorship groups to identify refugees in need of resettlement.

“Our first priority is the safety of Uyghur refugees. We therefore cannot provide any details on our efforts or plans since it could put this vulnerable population at risk,” Lariviere said.

Source: Voice of America

October 27, 2022

GORE COMPLETES ENROLLMENT IN THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS EXPAND REGISTRY.

This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases.

PUTZBRUNN, Germany, Oct. 27, 2022 /PRNewswire/ — W. L. Gore & Associates, Inc. (Gore) announced the completion of target enrollment in the EXPAND Post-Market Registry of the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft). 280 patients at 15 European sites have been enrolled to collect safety and performance data of the VBX Stent Graft to evaluate how the device performs in real-world cases and to continue their commitment to advancing patient care in the treatment of various diseases.

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

The EXPAND registry

This prospective, multicenter registry offers an opportunity to understand the varied usages for the VBX Stent Graft to treat different pathologies in a wide range of anatomical locations. These include lesion exclusion (non-iatrogenic, such as aneurysmatic disease, or iatrogenic, inclusive of ruptures or perforation), visceral perfusion (including fenestrated/branched bridging stent), luminal reconstruction (arteriovenous fistulas) or occlusive disease with the exception of de novo iliac occlusive disease. De novo iliac occlusive disease was already captured in the Gore VBX FLEX Clinical Study, which reported robust procedural success and durable clinical outcomes through three years, with 96.9% primary patency at nine months and 91.2% freedom from target lesion revascularization (TLR) at three years.

“Currently we do not have real-world data to evaluate the variety of covered balloon expandable devices in the different anatomies. Using EXPAND to understand the safety and performance of the VBX Stent Graft in these anatomical locations, alongside the VBX FLEX trial, is key to determining future treatment options for our vascular patients with this device”, said Prof. Mauro Gargiulo, Chair of Metropolitan Unit of Vascular Surgery at IRCCS S. Orsola Hospital in Bologna and Principal Investigator of the Registry.

Patients enrolled in EXPAND registry will be followed for five years, with a primary endpoint evaluating procedural success and freedom from VBX Stent Graft-related serious adverse event at 30 days, and secondary endpoints on safety and efficacy through five years.

“The EXPAND registry will help us advance our patient care and improve our clinical outcomes based on the long-term real-world evidence it will provide”, commented Dr. Martin Austermann, Director of the Clinic for Vascular Surgery at St. Franziskus Hospital in Münster, the site that has enrolled the most number of patients. “Of considerable appeal is evaluating the use of the VBX Stent Graft as a bridging stent for complex aortic fenestrated and branched endovascular repair. Gore is the first company with a real-world registry capturing these categories and whose one year follow-up has recently been presented at Charing Cross and LINC congresses.” continued Dr. Austermann.

GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis offers precise delivery and supports positive outcomes in complex aortoiliac applications. The device was developed utilizing the small diameter, ePTFE stent graft technology from the GORE^® VIABAHN^® Endoprosthesis. The VBX Stent Graft is available in a range of diameters from 5 to 11 mm and lengths of 15, 19, 29, 39, 59 and 79 mm to cover a wide variety of treatment needs.

EXPAND is part of Gore’s dedication to post-market surveillance and monitoring long-term device performance in an effort to improve clinical practice and patient outcomes. Data will be representative of real-world, clinical use. Real-world clinical use data are integral for Gore, combined with data from long-term clinical investigations and reports from medical literature, to perform continuing assessments of device performance in addition to any long-term clinical investigations as well as reports in medical journals and congress presentations.

“EXPAND provides an invaluable resource not only for Gore, but also for our physicians,” said Jenny Hoffmann, Gore Peripheral Business Leader. “We are committed to collecting real-world data on our devices, and through sharing it with the wider physician community, it allows us to truly realise our vision of Together, improving life.”

For more information about the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis, visit https://www.goremedical.com/eu/products/vbx

* For complete indications and other important safety information for Gore commercial products referenced herein, refer to the applicable Instructions for Use (IFU).

Gore engineers medical devices that treat a range of cardiovascular and other health conditions. With more than 50 million medical devices implanted over the course of more than 45 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives.

goremedical.com/eu

About Gore

W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 11,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $3.8 billion.

gore.com

Products listed may not be available in all markets.

GORE, Together, improving life, VBX, VBX FLEX, VIABAHN and designs are trademarks of W. L. Gore & Associates.

Photo – https://mma.prnewswire.com/media/1927080/GORE_VBX__2022.jpg
Logo – https://mma.prnewswire.com/media/1633961/W_L_Gore_Associates_Logo.jpg

October 27, 2022

GORE CLÔTURE L’ENREGISTREMENT DES PATIENTS DANS LE REGISTRE DE L’ENDOPROTHÈSE EXPANSIBLE SUR BALLONNET GORE® VIABAHN® VBX.

Ce registre confirmera l’innocuité et la performance de l’endoprothèse VBX dans les vaisseaux périphériques chez les patients qui nécessitent un traitement chirurgical dans une variété d’applications et de maladies.

PUTZBRUNN, Allemagne, 27 octobre 2022/PRNewswire/ — W. L. Gore & Associates, Inc. (Gore) a annoncé l’achèvement du recrutement cible dans le registre post-commercialisation EXPAND de l’Endoprothèse expansible sur ballonnet GORE® VIABAHN® VBX (endoprothèse VBX). 280 patients sur 15 sites européens ont été enrôlés pour recueillir les données d’innocuité et de performance de l’endoprothèse VBX afin d’évaluer comment le dispositif se comporte dans des cas réels et de poursuivre leur engagement à faire progresser les soins apportés aux patients dans le traitement de diverses maladies.

Le registre EXPAND

Ce registre prospectif et multicentrique offre l’opportunité de comprendre les utilisations variées de l’endoprothèse VBX pour traiter différentes pathologies dans un large éventail de localisations anatomiques. Il s’agit notamment de l’exclusion de lésions (non iatrogènes, comme la maladie anévrismale, ou iatrogènes, incluant les ruptures ou les perforations), de la perfusion viscérale (dont l’endoprothèse de pontage fenestrée/ramifiée), de la reconstruction luminale (fistules artérioveineuses) ou de la maladie occlusive à l’exception de la maladie occlusive iliaque de novo. Cette dernière a déjà été prise en compte dans l’étude clinique VBX FLEX de Gore, qui a fait état d’un solide succès procédural et de résultats cliniques durables sur trois ans, avec 96,9 % de perméabilité primaire à neuf mois et 91,2 % d’absence de revascularisation de la lésion cible (TLR) à trois ans.

« Actuellement, nous ne disposons pas de données issues du monde réel pour évaluer la variété des dispositifs expansibles à ballonnet couvert dans les différentes anatomies. L’utilisation d’EXPAND pour comprendre l’innocuité et la performance de l’endoprothèse VBX dans ces emplacements anatomiques, parallèlement à l’essai VBX FLEX, est essentielle pour déterminer les futures options de traitement de nos patients vasculaires avec ce dispositif », a déclaré le professeur Mauro Gargiulo, président de l’unité métropolitaine de chirurgie vasculaire de l’hôpital IRCCS S. Orsola de Bologne et chercheur principal du Registre.

Les patients inscrits dans le registre EXPAND seront suivis pendant cinq ans, avec un critère primaire évaluant le succès de la procédure et l’absence d’événement indésirable grave lié à l’endoprothèse VBX à 30 jours, et des critères secondaires sur la sécurité et l’efficacité pendant cinq ans.

« Le registre EXPAND nous aidera à faire progresser les soins prodigués à nos patients et à améliorer nos résultats cliniques grâce aux preuves réelles à long terme qu’il fournira », a commenté le Dr Martin Austermann, directeur de la clinique de chirurgie vasculaire de l’hôpital St. Franziskus de Münster, le site qui a recruté le plus grand nombre de patients. « L’évaluation de l’utilisation de l’endoprothèse VBX comme endoprothèse de pontage pour les réparations endovasculaires complexes fenestrées et ramifiées de l’aorte présente un intérêt considérable. Gore est la première société à disposer d’un registre du monde réel capturant ces catégories et dont le suivi à un an a récemment été présenté aux congrès Charing Cross et LINC », poursuit le Dr Austermann.

L’Endoprothèse expansible sur ballonnet GORE® VIABAHN® VBX offre une pose précise et favorise des résultats positifs dans les applications aorto-iliaques complexes. Le dispositif a été développé en utilisant la technologie d’endoprothèse de petit diamètre en PTFE expansé de l’endoprothèse GORE^® VIABAHN^®. L’endoprothèse VBX est disponible dans une gamme de diamètres de 5 à 11 mm et de longueurs de 15, 19, 29, 39, 59 et 79 mm pour couvrir une grande variété de besoins de traitement.

L’étude EXPAND fait partie de l’engagement de Gore dans la surveillance post-commercialisation et le suivi des performances à long terme des dispositifs dans le but d’améliorer la pratique clinique et les résultats pour les patients. Les données seront représentatives d’une utilisation clinique réelle. Les données relatives à l’utilisation clinique en situation réelle font partie intégrante de l’évaluation continue des performances des dispositifs par Gore. Elles sont combinées aux données issues des investigations cliniques à long terme et aux rapports de la littérature médicale, en plus de toute investigation clinique à long terme ainsi que des rapports publiés dans les revues médicales et des présentations de congrès.

« EXPAND constitue une ressource inestimable non seulement pour Gore, mais aussi pour nos médecins », a déclaré Jenny Hoffmann, responsable des activités périphériques de Gore. « Nous nous engageons à collecter des données du monde réel sur nos dispositifs, et en les partageant avec la communauté élargie des médecins, cela nous permet de réaliser véritablement notre vision de Together, improving life (Ensemble, améliorons la vie). »

Pour plus d’informations sur l’Endoprothèse expansible sur ballonnet GORE® VIABAHN® VBX, visitez le site https://www.goremedical.com/eu/products/vbx

* Pour connaître les indications complètes et d’autres informations importantes sur l’innocuité des produits commerciaux de Gore mentionnés dans le présent document, reportez-vous aux instructions d’utilisation (IFU) applicables.

Gore conçoit des dispositifs médicaux qui traitent toute une série d’affections cardiovasculaires et autres. Avec plus de 50 millions de dispositifs médicaux implantés au cours de plus de 45 ans, Gore s’appuie sur son héritage pour améliorer les résultats des patients par le biais de la recherche, de l’éducation et des initiatives de qualité. La performance des produits, leur facilité d’utilisation et la qualité de leur service permettent aux médecins, aux hôpitaux et aux assureurs de réaliser des économies durables. Gore est au service des cliniciens et, grâce à cette collaboration, nous améliorons des vies.

goremedical.com/eu

À propos de Gore

W. L. Gore & Associates est une entreprise mondiale de science des matériaux qui se consacre à la transformation des industries et à l’amélioration des vies. Depuis 1958, Gore a résolu des défis techniques complexes dans des environnements exigeants – de l’espace aux plus hauts sommets du monde en passant par le fonctionnement interne du corps humain. Avec plus de 11 000 associés et une forte culture d’équipe, Gore génère des revenus annuels de 3,8 milliards de dollars.

gore.com

Les produits énumérés peuvent ne pas être disponibles sur tous les marchés.

GORE, Together, improving life, VBX, VBX FLEX, VIABAHN et les dessins sont des marques déposées de W. L. Gore & Associates.

Photo – https://mma.prnewswire.com/media/1927080/GORE_VBX__2022.jpg

Logo – https://mma.prnewswire.com/media/1633961/W_L_Gore_Associates_Logo.jpg